Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics of Vitiligo: A Review. | Clin Cosmet Investig Dermatol | 2026 | 41789055 | PubTator, text mining | PubMed |
| Quercetin and Its Nano-Based Formulations Against Skin Cancer: A Narrative Review. | Health Sci Rep | 2026 | 41773219 | PubTator, text mining | PubMed |
| Genetic architecture of multiple primary cutaneous melanoma in the absence of high-penetrance susceptibility genes. | J Invest Dermatol | 2026 | 41763641 | PubTator, text mining | PubMed |
| Navigating the Challenges of Metallopharmaceutical Agents: Strategies and Predictive Modeling for Skin Cancer Therapy. | Pharmaceutics | 2026 | 41754887 | PubTator, text mining | PubMed |
| Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. | Life (Basel) | 2026 | 41752902 | PubTator, text mining | PubMed |
| Implementation Outcomes of the National Skin Smart Campus Initiative Among Young Adults. | Int J Environ Res Public Health | 2026 | 41752248 | PubTator, text mining | PubMed |
| Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma. | Int J Mol Sci | 2026 | 41751850 | PubTator, text mining | PubMed |
| Exploring Autosomal Dominant Non-Syndromic Monogenic Obesity: From Genes to Therapy. | Curr Issues Mol Biol | 2026 | 41751424 | PubTator, text mining | PubMed |
| Chromosome 3p Deletion Leads to Extensive Genomic Alterations in Diverse Cancers and Confers Synthetic Lethality in Uveal Melanoma. | Cancers (Basel) | 2026 | 41749941 | PubTator, text mining | PubMed |
| Dissecting the Impact of α-MSH-MC1R-cAMP Signaling on UVA-Induced Stress in Fibroblasts - Implications for Regulation of Cutaneous Photoaging. | Aging Dis | 2026 | 41747169 | PubTator, text mining | PubMed |
| Is Thiourea the Weak Link? An Investigation of the In Vitro and In Vivo Destabilization of [203Pb]- and [212Pb]Pb2+ Thiourea-Based Bioconjugates. | ACS Bio Med Chem Au | 2026 | 41726328 | PubTator, text mining | PubMed |
| Functional polymorphisms in pigmentation-related genes MC1R and DCT display population-specific association with wet age-related macular degeneration. | Biochem Biophys Rep | 2026 | 41694669 | PubTator, text mining | PubMed |
| Rare Germline Variants in CDKN2A-Negative Children and Adolescents With Cutaneous Melanoma. | Pigment Cell Melanoma Res | 2026 | 41673532 | PubTator, text mining | PubMed |
| Robust imputation-based method for eye, hair, and skin colour prediction from low-coverage ancient DNA. | Sci Rep | 2026 | 41644996 | PubTator, text mining | PubMed |
| Personalized surveillance in giant congenital melanocytic nevus, including the role of AI, histopathology and MC1R genotyping: A case report. | Biomed Rep | 2026 | 41624622 | PubTator, text mining | PubMed |
| Enzymatic preparation of epigallocatechin gallate diglucoside and bioactivity assessment. | AMB Express | 2026 | 41621019 | PubTator, text mining | PubMed |
| ZDHHC4-mediated ZEB-2 S-palmitoylation promotes melanoma epithelial-mesenchymal transition via deubiquitinating and stabilizing ZEB-2. | Cell Mol Life Sci | 2026 | 41603995 | PubTator, text mining | PubMed |
| Blocking ASIP to Protect MC1R Signaling and Mitigate Melanoma Risk: An In Silico Study. | Pharmaceuticals (Basel) | 2026 | 41599712 | PubTator, text mining | PubMed |
| Monopolar Radiofrequency for Facial Hyperpigmentation Treatment: An Integrated Retrospective Clinical Trial and Ex Vivo Study. | Int J Mol Sci | 2026 | 41596410 | PubTator, text mining | PubMed |
| Corneal macrophages and limbal stem cells: emerging roles in ocular surface regeneration. | Ann Med | 2026 | 41552884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=3